{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:11:08Z","timestamp":1791695468790,"version":"4.3.4"},"reference-count":121,"publisher":"Elsevier","isbn-type":[{"value":"9780323853231","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pmbts.2021.01.017","type":"book-chapter","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T09:37:16Z","timestamp":1614159436000},"page":"165-183","source":"Crossref","is-referenced-by-count":26,"title":["CRISPR-Cas9 for treating hereditary diseases"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2021.01.017_bb0010","series-title":"2014 Report on the State of the Art of Rare Disease Activities in Europe Part II: Key Developments in the Field of Rare Diseases in Europe in 2013","first-page":"1","year":"2014"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0015","author":"WHO Report"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0020","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0025","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11427-016-0192-5","article-title":"A novel RNA-guided RNA-targeting CRISPR tool","volume":"59","author":"Zhang","year":"2016","journal-title":"Sci China Life Sci"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J Mol Evol"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/mic.0.27437-0","article-title":"CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies","volume":"151","author":"Pourcel","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0040","series-title":"Chapter in Precision Medicine for Investigators, Practitioners and Providers","first-page":"59","article-title":"CRISPR technology for genome editing","author":"Bhattacharjee","year":"2019"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.017_bb0045","first-page":"293","article-title":"CRISPR\/Cas-9 system: magnificent tool for genome editing","volume":"3","author":"Vasdev","year":"2017","journal-title":"Int J Biotech Bioeng"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0050","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s11427-016-0358-3","article-title":"From the first human gene-editing to the birth of three-parent baby","volume":"59","author":"Zhang","year":"2016","journal-title":"Sci China Life Sci"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.017_bb0055","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.017_bb0060","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0065","first-page":"191","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"19","author":"Chang","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0070","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"9371","key":"10.1016\/bs.pmbts.2021.01.017_bb0080","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Bolton-Maggs","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.017_bb0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional correction of large factor VIII gene chromosomal inversions in hemophilia a patient-derived iPSCs using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"26","key":"10.1016\/bs.pmbts.2021.01.017_bb0090","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood.2019000790","article-title":"CRISPR\/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX-knockout mice","volume":"133","author":"Wang","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.017_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12185-019-02765-0","article-title":"CRISPR\/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs","volume":"111","author":"Morishige","year":"2020","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.017_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","article-title":"Beta-thalassemia","volume":"12","author":"Cao","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0105","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1101\/gr.173427.114","article-title":"Seamless gene correction of \u03b2-thalassemia mutations in patient-specific iPSCs using CRISPR\/Cas9 and piggyBac","volume":"24","author":"Xie","year":"2014","journal-title":"Genome Res"},{"issue":"9","key":"10.1016\/bs.pmbts.2021.01.017_bb0110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00439-018-1933-9","article-title":"Application of CRISPR\/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases","volume":"137","author":"Cai","year":"2018","journal-title":"Hum Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0115","article-title":"Chinese scientists genetically modify human embryos","author":"Cyranoski","year":"2015","journal-title":"Nature News"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","article-title":"Correction of a genetic disease in mouse via use of CRISPR-Cas9","volume":"13","author":"Wu","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5966\/sctm.2015-0157","article-title":"Na\u00efve induced pluripotent stem cells generated from \u03b2-thalassemia fibroblasts allow efficient gene correction with CRISPR\/Cas9","volume":"5","author":"Yang","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40348-018-0086-1","article-title":"Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors","volume":"5","author":"Antony","year":"2018","journal-title":"Mol Cell Pediatr"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.017_bb0135","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2174\/138161212799315984","article-title":"New therapies in cystic fibrosis","volume":"18","author":"Ratjen","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0140","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"5121","article-title":"Cystic fibrosis","author":"Welsh","year":"2001"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.017_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/genes10050387","article-title":"Gene and base editing as a therapeutic option for cystic fibrosis-learning from other diseases","volume":"10","author":"Mention","year":"2019","journal-title":"Genes (Basel)"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.017_bb0150","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0155","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","article-title":"Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis","volume":"63","author":"Cheng","year":"1990","journal-title":"Cell"},{"issue":"19","key":"10.1016\/bs.pmbts.2021.01.017_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123529","article-title":"A sheep model of cystic fibrosis generated by CRISPR\/Cas9 disruption of the CFTR gene","volume":"3","author":"Fan","year":"2018","journal-title":"JCI Insight"},{"issue":"3A","key":"10.1016\/bs.pmbts.2021.01.017_bb0165","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(97)00262-3","article-title":"Current concepts in the pathogenesis of Alzheimer's disease","volume":"103","author":"Carr","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000327171","article-title":"Genetic associations of autopsy-confirmed vascular dementia subtypes","volume":"31","author":"Jones","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.017_bb0175","first-page":"439","article-title":"The potential of CRISPR\/Cas9 gene editing as a treatment strategy for Alzheimer's disease","volume":"8","author":"Rohn","year":"2018","journal-title":"J Alzheimer's Dis Parkinsonism"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2021.01.017_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2006.06.072","article-title":"Chinese Presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SY5Y neuroblastoma cells","volume":"406","author":"Fang","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0185","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1038\/celldisc.2016.26","article-title":"Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to \u03b3-secretase cleavage and the A\u03b242\/A\u03b240 ratio","volume":"2","author":"Xu","year":"2016","journal-title":"Cell Discov"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0190","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/475S20a","article-title":"Genetics: finding risk factors","volume":"475","author":"Eisenstein","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.017_bb0195","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jcyt.2019.04.022","article-title":"ApoE4 allele specific knockout using a synthetic Cas9 variant as a potential gene therapy approach for Alzheimer's disease","volume":"21","author":"Rabinowitz","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0200","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms","volume":"256","author":"Weisgraber","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"issue":"7603","key":"10.1016\/bs.pmbts.2021.01.017_bb0210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0215","series-title":"Huntington's Disease","first-page":"3","author":"Bates","year":"2002"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington's disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0225","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0230","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0235","series-title":"Genome Editing in Neurosciences [Internet]","article-title":"Using genome engineering to understand Huntington's disease","author":"Bailus","year":"2017"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0240","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-4939-9784-8_17","article-title":"Gene therapy for Huntington's disease using targeted endonucleases","volume":"2056","author":"Dabrowska","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 editing of the mutant Huntingtin allele in vitro and in vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0250","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-1-4939-7825-0_21","article-title":"CRISPR\/Cas9-mediated genome editing for Huntington's disease","volume":"1780","author":"Vachey","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0255","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1172\/JCI92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease","volume":"127","author":"Yang","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0260","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","article-title":"CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington's disease mouse model","volume":"17","author":"Ekman","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0265","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1055\/s-0028-1114024","article-title":"Dopamine (3-hydroxytyramine) in the central nervous system and its relation to the Parkinson syndrome in man","volume":"87","author":"Hornykiewicz","year":"1962","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0270","series-title":"Neuroscience","author":"Purves","year":"2008"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.017_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10.1016\/bs.pmbts.2021.01.017_bb0280","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"7628","key":"10.1016\/bs.pmbts.2021.01.017_bb0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature20414","article-title":"Defects in trafficking bridge Parkinson's disease pathology and genetics","volume":"539","author":"Abeliovich","year":"2016","journal-title":"Nature"},{"issue":"16","key":"10.1016\/bs.pmbts.2021.01.017_bb0290","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.017_bb0295","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat Genet"},{"issue":"6676","key":"10.1016\/bs.pmbts.2021.01.017_bb0300","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.017_bb0305","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.017_bb0310","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.nbd.2012.07.017","article-title":"LRRK2 expression is enriched in the striosomal compartment of mouse striatum","volume":"48","author":"Mandemakers","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"5321","key":"10.1016\/bs.pmbts.2021.01.017_bb0315","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.017_bb0320","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn.2017.25","article-title":"The two-century journey of Parkinson disease research","volume":"18","author":"Przedborski","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0325","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1038\/s41598-020-60273-2","article-title":"In vitro CRISPR\/Cas9-directed gene editing to model LRRK2 G2019S Parkinson's disease in common Marmosets","volume":"10","author":"Vermilyea","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.017_bb0330","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ejn.14286","article-title":"Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene","volume":"49","author":"Chen","year":"2019","journal-title":"Eur J Neurosci"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0335","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-019-0321-9","article-title":"A CRISPR monkey model unravels a unique function of PINK1 in primate brains","volume":"14","author":"Yang","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0340","first-page":"13","article-title":"Treatment adherence in type 1 hereditary tyrosinaemia (HT1): a mixed-method investigation into the beliefs, attitudes and behaviour of adolescent patients, their families and their health-care team","volume":"18","author":"Malik","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0345","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hep.23481","article-title":"Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo","volume":"51","author":"Paulk","year":"2010","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/bs.pmbts.2021.01.017_bb0350","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1089\/hum.2017.252","article-title":"Curative ex vivo hepatocyte-directed gene editing in a mouse model of hereditary tyrosinemia type 1","volume":"29","author":"VanLith","year":"2018","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.017_bb0355","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.a.61026","article-title":"Gene editing successfully corrects 2 amino acid disorders: in 2 preclinical studies using CRISPR-mediated gene editing, phenylketonuria and hereditary tyrosinemia type 1 were corrected","volume":"179","author":"Nelson","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"18","key":"10.1016\/bs.pmbts.2021.01.017_bb0360","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1074\/jbc.RA117.000347","article-title":"Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats","volume":"293","author":"Shao","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0365","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.017_bb0370","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41551-019-0357-8","article-title":"Adenine base editing in an adult mouse model of tyrosinaemia","volume":"4","author":"Song","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.017_bb0375","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41591-018-0184-6","article-title":"In utero CRISPR-mediated therapeutic editing of metabolic genes","volume":"24","author":"Rossidis","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0380","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0385","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/338259a0","article-title":"Association of dystrophin and an integral membrane glycoprotein","volume":"338","author":"Campbell","year":"1989","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0390","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/345315a0","article-title":"Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle","volume":"345","author":"Ervasti","year":"1990","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0395","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2014a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0400","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: one gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.omtn.2017.02.004","article-title":"Correction of the exon 2 duplication in DMD myoblasts by a single CRISPR\/Cas9 system","volume":"7","author":"Lattanzi","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"10.1016\/bs.pmbts.2021.01.017_bb0410","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.117.310996","article-title":"In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice","volume":"121","author":"El Refaey","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0415","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","article-title":"Precise correction of the dystrophin gene in Duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9","volume":"4","author":"Li","year":"2015","journal-title":"Stem Cell Rep"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0420","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajhg.2015.11.012","article-title":"Spell checking nature: versatility of CRISPR\/Cas9 for developing treatments for inherited disorders","volume":"98","author":"Wojtal","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.58","article-title":"Efficient restoration of the dystrophin gene reading frame and protein structure in DMD myoblasts using the cinDel method","volume":"5","author":"Iyombe-Engembe","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0430","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0435","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nbt.4148","article-title":"Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy","volume":"36","author":"Ryu","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0440","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ymthe.2018.08.010","article-title":"CRISPR-induced deletion with saCas9 restores dystrophin expression in dystrophic models in vitro and in vivo","volume":"26","author":"Duchene","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0445","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/TACG.S49628","article-title":"Tay-Sachs disease: current perspectives from Australia","volume":"8","author":"Lew","year":"2015","journal-title":"Appl Clin Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0450","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl Sci Rare Dis"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0455","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","article-title":"Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis","volume":"33","author":"Sandho","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0460","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.0.CO;2-7","article-title":"Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene","volume":"9","author":"Myerowitz","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0465","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nm0496-424","article-title":"Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells","volume":"2","author":"Lacorazza","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0470","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/hmg\/8.5.831","article-title":"Adenoviral gene therapy of the Tay-Sachs disease in hexosaminidase A-deficient knock-out mice","volume":"8","author":"Guidotti","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0475","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/hum.2017.163","article-title":"Adeno-associated virus gene therapy in a sheep model of Tay-Sachs disease","volume":"29","author":"Gray-Edwards","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0480","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1194\/jlr.M081323","article-title":"Cerebral organoids derived from Sandho disease-induced pluripotent stem cells exhibit impaired neurodifferentiation","volume":"59","author":"Allende","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0485","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0490","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1038\/mtm.2015.57","article-title":"Construction of a hybrid beta-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo","volume":"3","author":"Tropak","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0495","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0500","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0092-8674(91)90283-5","article-title":"Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox","volume":"67","author":"Fu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0505","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/humrep\/deh635","article-title":"Association of FMR1 repeat size with ovarian dysfunction","volume":"20","author":"Sullivan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0510","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/nn1765","article-title":"Fragile X syndrome and autism at the intersection of genetic and neural networks","volume":"9","author":"Belmonte","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0515","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ejhg.2008.61","article-title":"Fragile X syndrome","volume":"16","author":"Garber","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0520","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-pathol-011811-132457","article-title":"Molecular mechanisms of fragile X syndrome: a twenty-year perspective","volume":"7","author":"Santoro","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0525","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/ajmg.a.31416","article-title":"Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation","volume":"A140","author":"Rauch","year":"2006","journal-title":"Am J Med Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0530","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/ajmg.a.32261","article-title":"Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature","volume":"A146","author":"Coffee","year":"2008","journal-title":"Am J Med Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0535","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/ajmg.a.33626","article-title":"Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males","volume":"A152","author":"Collins","year":"2010","journal-title":"Am J Med Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0540","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.celrep.2015.08.084","article-title":"Reversion of FMR1 methylation and silencing by editing the triplet repeats in fragile x IPSC-derived neurons","volume":"13","author":"Park","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165499","article-title":"Reactivation of FMR1 by CRISPR\/cas9-mediated deletion of the expanded CGG-repeat of the fragile x chromosome","volume":"11","author":"Xie","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0550","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2018.01.012","article-title":"Rescue of fragile x syndrome neurons by DNA methylation editing of the FMR1 gene","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0555","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fnmol.2018.00282","article-title":"Targeted reactivation of fmr1 transcription in fragile x syndrome embryonic stem cells","volume":"11","author":"Haenfler","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0560","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10519-020-09995-7","article-title":"Hyperactivity, memory defects, and craniofacial abnormalities in Zebrafish fmr1 mutant larvae","volume":"50","author":"Hu","year":"2020","journal-title":"Behav Genet"},{"issue":"20","key":"10.1016\/bs.pmbts.2021.01.017_bb0565","first-page":"4566","article-title":"Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR\/Cas9","volume":"25","author":"Shin","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0570","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s10038-017-0400-0","article-title":"A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR\/Cas9 and evaluation of antisense-mediated exon skipping","volume":"63","author":"Shimo","year":"2018","journal-title":"J Hum Genet"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0575","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.18632\/oncotarget.23730","article-title":"CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes","volume":"9","author":"Zhao","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0580","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/stem.1969","article-title":"Production of gene-corrected adult beta globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation","volume":"33","author":"Huang","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0585","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.98","article-title":"Restoring ureagenesis in hepatocytes by CRISPR\/Cas9-mediated genomic addition to arginase-deficient induced pluripotent stem cells","volume":"5","author":"Lee","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.09.015","article-title":"The role of insulin-like growth factor 1 in ALS cell and mouse models: a mitochondrial protector","volume":"144","author":"Wen","year":"2019","journal-title":"Brain Res Bull"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0595","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14716","article-title":"Nrl knockdown by AAV-delivered CRISPR\/Cas9 prevents retinal degeneration in mice","volume":"8","author":"Yu","year":"2017","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.017_bb0600","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.exphem.2015.06.002","article-title":"CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells","volume":"43","author":"Flynn","year":"2015","journal-title":"Exp Hematol"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.017_bb0605","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/j.pain.0000000000001002","article-title":"CRISPR\/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-lacosamide","volume":"158","author":"Moutal","year":"2017","journal-title":"Pain"},{"key":"10.1016\/bs.pmbts.2021.01.017_bb0610","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.omtm.2019.12.004","article-title":"AAV-mediated CRISPR\/Cas9 gene editing in murine phenylketonuria","volume":"17","author":"Richards","year":"2019","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Progress in Molecular Biology and Translational Science","Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117321000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117321000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:18:12Z","timestamp":1753355892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117321000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780323853231"],"references-count":121,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2021.01.017","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}